Published June 1, 2006 | Version v1
Journal article

Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells

  • 1. Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232 (United States)
  • 2. Department of Dermatology and Allergology, University Hospital of the RWTH, Aachen (Germany)
  • 3. Department of Medicine/Dermatology, Vanderbilt University School of Medicine, Nashville, TN 37232 (United States)
  • 4. Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112 (United States)
  • 5. VA Tennessee Valley Healthcare System, Nashville, TN 37212 (United States) and Department of Medicine/Dermatology, Vanderbilt University School of Medicine, Nashville, TN 37232 (United States) and Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232 (United States)

Description

Epoxyeicosatrienoic acids produced by mouse CYP2B19 have been implicated in mechanisms regulating epidermal cornification (Ladd, P.A., Du, L., Capdevila, J.H., Mernaugh, R., Keeney, D.S., 2003. Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J. Biol. Chem. 278, 35184-35192). In this study, we aimed to identify CYPs that are up-regulated during keratinocyte differentiation and potentially responsible for epoxyeicosatrienoic acid formation in human skin. The cellular differentiation state of human epidermal cell cultures was manipulated to resemble the basal, spinous, and granular cell phenotypes in vivo. Changes in CYP mRNA levels were measured as a function of differentiation state for a panel of 15 CYPs that included known and putative arachidonate monooxygenases. Quantitative real-time PCR analyses showed that all of the CYPs were expressed in differentiating epidermal cell cultures and in human epidermis, with the exception of CYP2B6, which was poorly expressed in vitro. Six CYPs were strongly up-regulated at Day 6 and Day 8 of in vitro differentiation (CYP4B1, 2W1, 2C18, 3A4, 2C19, 2C9); the increase in mRNA levels ranged from 27- to 356-fold. Only CYP2U1 mRNA levels decreased (6-fold change) during cellular differentiation. Six CYPs showed little variation (<2-fold change) in mRNA levels during in vitro differentiation (CYP2S1, 2J2, 1B1, 1A1, 2E1, 2D6). No single CYP was identifiable as being a functional counterpart to CYP2B19 in mouse skin since none qualified as being mainly responsible for epidermal epoxyeicosatrienoic acid formation. Rather, the data suggest that epoxyeicosatrienoic acids in human skin are formed by several CYPs expressed in different cell layers of the epidermis. This would predict that CYP-derived eicosanoids have different functions in different epidermal cell layers

Additional details

Identifiers

DOI
10.1016/j.taap.2005.10.003;
PII
S0041-008X(05)00598-3;

Publishing Information

Journal Title
Toxicology and Applied Pharmacology
Journal Volume
213
Journal Issue
2
Journal Page Range
p. 135-144
ISSN
0041-008X
CODEN
TXAPA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
38020797
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CELL CULTURES; EPIDERMIS; GENES; IN VITRO; IN VIVO; MICE; PHENOTYPE; POLYMERASE CHAIN REACTION
Descriptors DEC
ANIMAL TISSUES; ANIMALS; BODY; EPITHELIUM; GENE AMPLIFICATION; MAMMALS; ORGANS; RODENTS; SKIN; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.